Tradewinds LLC’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$584K Buy
4,436
+107
+2% +$15K 0.19% 72
2025
Q4
$531K Sell
4,329
-238
-5% -$28.9K 0.13% 107
2025
Q3
$507K Buy
+4,567
New +$519K 0.12% 111
2025
Q2
Sell
-4,537
Closed -$508K 150
2025
Q1
$508K Sell
4,537
-159
-3% -$16.4K 0.14% 115
2024
Q4
$450K Sell
4,696
-490
-9% -$44.1K 0.13% 127
2024
Q3
$435K Sell
5,186
-279
-5% -$21.3K 0.13% 120
2024
Q2
$375K Buy
+5,465
New +$365K 0.12% 137
2023
Q3
$429K Sell
5,727
-70
-1% -$5.38K 0.25% 68
2023
Q2
$447K Buy
5,797
+121
+2% +$9.65K 0.26% 67
2023
Q1
$471K Buy
+5,676
New +$470K 0.29% 67
2022
Q4
Sell
-5,577
Closed -$344K 152
2022
Q3
$344K Buy
5,577
+1,004
+22% +$63.3K 0.25% 78
2022
Q2
$283K Buy
+4,573
New +$283K 0.19% 91

Other funds holding GILD

Tradewinds LLC's GILD Position: Q1 2026 in Review

Tradewinds LLC increased its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, buying an estimated $15K and bringing the position to 4,436 shares worth $584K. The position accounts for 0.19% of the portfolio, ranked #72.

Tradewinds LLC first reported a position in GILD in Q2 2022 and has held it in 12 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Tradewinds LLC held 4,436 shares of Gilead Sciences worth $584K as of Q1 2026.
  • Tradewinds LLC bought 107 Gilead Sciences shares in Q1 2026, an estimated $15K.
  • Gilead Sciences made up 0.19% of Tradewinds LLC's portfolio in Q1 2026, its #72 holding.
  • Tradewinds LLC first reported a position in Gilead Sciences in Q2 2022 and has held it in 12 quarters since.
  • 2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Tradewinds LLC's 13F filing for Q1 2026, filed 4 May 2026.